Who Make Dostarlimab?
Cancer has been one of the fatal diseases with no answer from medical science. However, Dostarlimab has got the eye of netizens as one of the hopes for the life-threatening disease, Cancer.
The study has shown unprecedented and unheard-of results in achieving complete remission in the trial. With such big hype, people are wondering who is the manufacturer of the cancer-treating drugs.
Manufacturer Company GlaxoSmithKline Stock
View this post on Instagram
Dostarlimab is mainly designed to block a particular protein involved in cancer cells called PD-1. On the report published on June 6 by healio, the drug has shown effectiveness as a curative treatment in the rectal cancer subset.
However, the whole report on effectiveness has not yet been published in the article. The drug still has some areas to work on, but the doctors believe the ray of hope is near.
Dostarlimab Efficacy as Cancer Drug: Is It Effective?
With recent reports coming out, Dostarlimab has been positive about its effectiveness as a cancer drug.
Dostarlimab demonstrated a 100% clinical complete response rate among a small cohort of patients with mismatch repair. However, for more clinical records, longer follow-up is required.
Read More: Does RuPaul Charles Really Have Or Is It Some Photoshop?
Comment on “Who Make Dostarlimab? Manufacturer And Stock Price Of Cancer Drug”